{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:39:53Z","timestamp":1792708793436,"version":"4.5.0"},"reference-count":98,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T00:00:00Z","timestamp":1690329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Focal segmental glomerulosclerosis (FSGS) is a common glomerular disorder that manifests clinically with the nephrotic syndrome and has a propensity to recur following kidney transplantation. The pathophysiology and therapies available to treat FSGS currently remain elusive. Since the podocyte appears to be the target of apparent circulating factor(s) that lead to recurrence of proteinuria following kidney transplantation, this article is focused on the podocyte. In the context of kidney transplantation, the performance of pre- and post-reperfusion biopsies, and the establishment of <jats:italic>in vitro<\/jats:italic> podocyte liquid biopsies\/assays allow for the development of clinically relevant studies of podocyte biology. This has given insight into new pathways, involving novel targets in innate and adaptive immunity, such as SMPDL3b, cGAS-STING, and B7-1. Elegant experimental studies suggest that the successful clinical use of rituximab and abatacept, two immunomodulating agents, in our case series, may be due to direct effects on the podocyte, in addition to, or perhaps distinct from their immunosuppressive functions. Thus, tissue biomarker-directed therapy may provide a rational approach to validate the mechanism of disease and allow for the development of new therapeutics for FSGS. This report highlights recent progress in the field and emphasizes the importance of kidney transplantation and recurrent FSGS (rFSGS) as a platform for the study of primary FSGS.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1201619","type":"journal-article","created":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T07:12:57Z","timestamp":1690355577000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["The podocyte: glomerular sentinel at the crossroads of innate and adaptive immunity"],"prefix":"10.3389","volume":"14","author":[{"suffix":"III","given":"George W.","family":"Burke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alla","family":"Mitrofanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Fontanella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Ciancio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Abitbol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayanthi","family":"Chandar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Merscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Fornoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfu035","article-title":"Focal segmental glomerulosclerosis: towards a better understanding for the practising nephrologist","volume":"30","author":"Sethi","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1106556","article-title":"Medical progress focal segmental glomerulosclerosis","volume":"365","author":"D\u2019Agati","year":"2011","journal-title":"NEngl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12045","article-title":"Recent progress in the pathophysiology and treatment of FSGS recurrence","volume":"13","author":"Cravedi","year":"2013","journal-title":"Amer J Transplant"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-021-00427-1","article-title":"Therapeutic trials in adult FSGS: lessons learned and the road forward","volume":"17","author":"DeVriese","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2006.01502.x","article-title":"Recurrent glomerulonephritis after kidney transplantation","volume":"6","author":"Choy","year":"2006","journal-title":"Am J Transplant"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-004-1706-7","article-title":"Recurrent focal l glomerulosclerosis in pediatric renal allografts: the Miami experience","volume":"20","author":"Hubsch","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2001.21311","article-title":"Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the united states","volume":"37","author":"Abbott","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001160","article-title":"Rituximab for recurrence of primary focal segmental glomerulosclerosis after kidney transplantation: clinical outcomes","volume":"101","author":"Garrouste","year":"2017","journal-title":"Transplantation"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e318250234a","article-title":"Podocyte foot process effacement in postreperfusion allograft biopsies correlates with early recurrence of proteinuria in focal segmental glomerulosclerosis","volume":"93","author":"Chang","year":"2012","journal-title":"Transplantation"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200202150-00009","article-title":"Proteinuria after injection of human focal segmental glomerulosclerosis factor","volume":"73","author":"Sharma","year":"2002","journal-title":"Transplantation"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1202500","article-title":"Resolution of recurrent focal segmental glomerulosclerosis after retransplantation","volume":"366","author":"Gallon","year":"2012","journal-title":"N Engl J Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01669","article-title":"Disease recurrence \u2013 the sword of Damocles in kidney transplantation for focal segmental glomerulosclerosis","volume":"10","author":"Kienzl-Wagner","year":"2019","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/nrneph.2014.216","article-title":"Causes and pathogenesis of focal segmental glomerulosclerosis","volume":"11","author":"Fogo","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3765608","article-title":"Circulating permeability factors in primary focal segmental glomerulosclerosis: a review of proposed candidates","volume":"9","author":"Konigshausen","year":"2016","journal-title":"BioMed Res Int"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12675","article-title":"Regulatory T cells and minimal change nephropathy: in the midst of a complex network","volume":"183","author":"Bertelli","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-016-0272-y","article-title":"Focal segmental glomerular sclerosis: do not overlook the role of immune response","volume":"29","author":"Reggiani","year":"2016","journal-title":"J Nephrol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01190216","article-title":"Clinical significance of IgM and C3 glomerular deposition in primary focal glomerulosclerosis","volume":"11","author":"Zhang","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI0212858","article-title":"Extrarenal effects on the pathogenesis and relapse of idiopathic nephrotic syndrome in Buffalo\/Mna rats","volume":"109","author":"LeBerre","year":"2001","journal-title":"J Clin Invest"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/14.3.713","article-title":"T Lymphocytes subsets and cytokine production by graft-infiltrating cells in FSGS recurrence post-transplantation","volume":"14","author":"De Oliveira","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-010-1507-0","article-title":"Characterization of renal immune cell infiltrates in children with nephrotic syndrome","volume":"25","author":"Benz","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc055495","article-title":"Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment","volume":"354","author":"Pescovitz","year":"2006","journal-title":"N Eng J Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181aed9d7","article-title":"Use of rituximab in focal glomerulosclerosis relapses after renal transplantation","volume":"88","author":"Dello Strologo","year":"2009","journal-title":"Transplantation"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2007.02021.x","article-title":"Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis","volume":"8","author":"Yabu","year":"2008","journal-title":"Am J Transplant"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2019.08.001","article-title":"Guardians of the cell: effector-triggered immunity steers mammalian immune defense","volume":"40","author":"Kufer","year":"2019","journal-title":"Trends Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1146\/annurev.iy.12.040194.005015","article-title":"Tolerance, danger and the extended family","volume":"12","author":"Matzinger","year":"1994","journal-title":"Annu Rev Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nri3521","article-title":"The speed of change: towards a discontinuity theory of immunity","volume":"13","author":"Pradeau","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2017.11.004","article-title":"Towards a general theory of immunity","volume":"39","author":"Eberl","year":"2018","journal-title":"Trends Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/01.mnh.0000444814.49755.90","article-title":"The emerging role of the inflammasome in kidney diseases","volume":"23","author":"Chang A","year":"2014","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1159\/000345255","article-title":"Antiviral innate immunity disturbs podocyte cell function","volume":"5","author":"Yamashita","year":"2013","journal-title":"J Innate Immun"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2013.122","article-title":"NOD-like and toll-like receptors or inflammasomes contribute to kidney disease in a canonical and a non-canonical manner","volume":"84","author":"Anders","year":"2013","journal-title":"Kidney lnt"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/srep22579","article-title":"Toll-like receptor 9 can be activated by endogenous mitochondrial DNA to induce podocyte apoptosis","volume":"6","author":"Bao","year":"2016","journal-title":"Sci Rep"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00122","article-title":"Innate immune activity in glomerular podocytes","volume":"8","author":"Xia","year":"2017","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/cddis.2015.125","article-title":"Podocyte apoptosis is prevented by blocking the toll-like receptor pathway","volume":"6","author":"Saurus","year":"2015","journal-title":"Cell Death Dis"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111","article-title":"Activation of NOD-like receptor protein 3 inflammasomes turns on podocyte injury and glomerulosclerosis in hyper homocysteinemia","volume":"60","author":"Zhang","year":"2012","journal-title":"Hypertension"},{"key":"B35","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.it.2015.12.003","article-title":"Integration of innate immune signaling","volume":"37","author":"Thaiss","year":"2016","journal-title":"Trends Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2011.05.003","article-title":"Immune signaling by RIG-i-like receptors","volume":"34","author":"Loo","year":"2011","journal-title":"Immunity"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2021.101286","article-title":"Activation of stimulator of interferon genes (STING) causes proteinuria and contributes to glomerular diseases","volume":"2021","author":"Mitofanova","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2022.01.004","article-title":"Emerging dimensions of cellular cGAS-STING signaling","volume":"74","author":"Guey","year":"2022","journal-title":"Curr Opin Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2017.03.004","article-title":"Evolutionary origins of cGAS-STING signaling","volume":"38","author":"Margolis","year":"2017","journal-title":"Trends Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2019.10.008","article-title":"Emerging role of mitochondrial DNA as a major driver of inflammation and disease progression","volume":"40","author":"Zhong","year":"2019","journal-title":"Trends Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2018.09.013","article-title":"Innate immunosensing of DNA in cellular senescence","volume":"56","author":"Gluck","year":"2019","journal-title":"Curr Opin Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2012020133","article-title":"Podocytes are nonhematopoietic professional antigen-presenting cells","volume":"24","author":"Goldwich","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1172\/JCI20402","article-title":"Induction of B7-1 in podocytes is associated with nephrotic syndrome","volume":"113","author":"Reiser","year":"2004","journal-title":"J Clin Invest"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1177\/0961203312451784","article-title":"Early treatment with glucocorticoids or cyclophosphamide retains the slit diaphragm proteins nephrin and podocin in experimental lupus nephritis","volume":"21","author":"Moysiadis","year":"2012","journal-title":"Lupus"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2016.06.003","article-title":"Innate antiviral defenses independent of inducible IFN alpha\/beta production","volume":"37","author":"Paludan","year":"2016","journal-title":"Trends Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/ncpneph0133","article-title":"Drug insight: rituximab in renal disease and transplantation","volume":"2","author":"Salama","year":"2006","journal-title":"Nat Clin Pract Nephrol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"85ra46","DOI":"10.1126\/scitranslmed.3002231","article-title":"Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis","volume":"2011","author":"Fornoni","year":"2011","journal-title":"Sci Transl Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-04-1769","article-title":"Generation of biologically active linear and cyclic peptides has revealed a unique fine specificity of rituximab and its possible crossreactivity with acid sphingomyelinase-like phosphodiesterase 3b precursor","volume":"107","author":"Perosa","year":"2006","journal-title":"Blood"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-01-0277","article-title":"Rituximab antiproliferative effect in b-lymphoma cells is associated with acid-sphingomyelinase activation in raft microdomains","volume":"104","author":"Bezombes","year":"2004","journal-title":"Blood"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/nm.1857","article-title":"The actin cystoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine a","volume":"14","author":"Faul","year":"2008","journal-title":"Nat Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"P.85ps21","DOI":"10.1126\/scitranslmed.3002429","article-title":"Rituximab\u2019s new therapeutic target: the podocyte actin cytoskeleton","volume":"3","author":"Chan","year":"2011","journal-title":"Sci Trans Med"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013111213","article-title":"SMPDL3b expression levels determine podocyte injury phenotypes in glomerular disease","volume":"26","author":"Yoo","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013040363","article-title":"Rituximab treatment prevents the early development of proteinuria following pig-to-baboon xeno-kidney transplantation","volume":"25","author":"Tasaki","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/nep.12737","article-title":"Rituximab protects podocytes and exerts anti-proteinuric effects in rat adriamycin-induced nephropathy independent of b-lymphocytes","volume":"22","author":"Takahashi","year":"2017","journal-title":"Nephrology"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.05.006","article-title":"The lipid-modifying enzyme SMPDL3B negatively regulates innate immunity","volume":"11","author":"Heinz","year":"2015","journal-title":"Cell Rep"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31829eda4f","article-title":"Podocyte effacement closely links to suPAR levels at time of posttransplantation focal segmental glomerulosclerosis occurrence and improves with therapy","volume":"96","author":"Alachkar","year":"2013","journal-title":"Transplantation"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000000053","article-title":"Podocyte foot process effacement in postreperfusion allograft biopsies","volume":"97","author":"Burke","year":"2014","journal-title":"Transplantation"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050524","article-title":"Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition","volume":"353","author":"Genovese","year":"2005","journal-title":"N Engl J Med"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2011.01386.x","article-title":"Belatacept: from rational design to clinical application","volume":"25","author":"Wekerle","year":"2012","journal-title":"Transplant Int"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1304572","article-title":"Abatacept in B7-1-positive proteinuric kidney disease","volume":"369","author":"Yu","year":"2013","journal-title":"N Engl J Med"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.06.022","article-title":"The costimulatory receptor B7-1 is not induced in injured podocytes","volume":"90","author":"Baye","year":"2016","journal-title":"Kidney Int"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00510.2015","article-title":"Any value of podocyte B7-1 as a biomarker in human MCD and FSGS","volume":"310","author":"Novelli","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2015080947","article-title":"Podocyte expression of B7-1\/CD80: is it a reliable biomarker for the treatment of proteinuric kidney diseases with abatacept","volume":"27","author":"Salant","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B64","first-page":"TH","article-title":"B7-1\/CD80 is not a reliable immunophenotypical marker of focal segmental glomerulosclerosis, membranous nephropathy, and diabetic nephropathy","volume":"25","author":"Laszik","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1053\/j.ajkd.2014.07.023","article-title":"B7-1 immunostaining in proteinuric kidney disease","volume":"64","author":"Larsen","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1111\/tri.12574","article-title":"Belatacept in recurrent focal segmental glomerulosclerosis after kidney transplantation","volume":"28","author":"Grellier","year":"2015","journal-title":"Transpl Int"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2015091002","article-title":"B7-1 blockade does not improve post-transplant nephrotic syndrome caused by recurrent FSGS","volume":"27","author":"Delville","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1400502","article-title":"Abatacept in B7-1-positive proteinuric kidney disease","volume":"370","author":"Alachkar","year":"2014","journal-title":"N Engl J Med"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1400502","article-title":"Abatacept in B7-1-positive proteinuric kidney disease","volume":"370","author":"Benigni","year":"2014","journal-title":"N Engl J Med"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-022-05549-7","article-title":"Benefit of B7-1 staining and abatacept for treatment-resistant post-transplant focal segmental glomerulosclerosis in a predominantly pediatric cohort: time for a reappraisal","volume":"38","author":"Burke","year":"2022","journal-title":"Pediatr Nephrol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-016-3379-4","article-title":"Pathogenesis of proteinuria in idiopathic minimal change disease: molecular mechanisms","volume":"31","author":"Cara-Fuentes","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfr271","article-title":"Toll-like receptor 3 ligands induce CD80 expression in human podocytes via an NF-kappa-B-dependent pathway","volume":"27","author":"Shimada","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M116.769273","article-title":"Crystal structure of the human alkaline sphingomyelinase provides insights into substrate recognition","volume":"292","author":"Gorelik","year":"2017","journal-title":"J Biol Chem"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1172\/JCI89626","article-title":"SGPL1 mutations cause nephrosis with ichthyosis and adrenal insufficiency","volume":"127","author":"Lovric","year":"2017","journal-title":"J Clin Invest"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-016-1049-8","article-title":"Increased urinary CD80 excretion and podocyturia in fabry disease","volume":"14","author":"Trimarchi","year":"2016","journal-title":"J Transl Med"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfs543","article-title":"Toll-like receptor 3, polyIC, induces proteinuria and glomerular CD80, and increases urinary CD80 in mice","volume":"28","author":"Ishimoto","year":"2013","journal-title":"Nephrol DialTransplant"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-022001026-8","article-title":"B7-1 mediates podocyte injury and glomerulosclerosis through communication with Hsp90ab1-LRP-Beta-catenin pathway","volume":"29","author":"Li","year":"2022","journal-title":"Cell Death Differ"},{"key":"B78","doi-asserted-by":"publisher","first-page":"6413012","DOI":"10.1155\/2018\/6413012","article-title":"Remaining physiological barriers in porcine kidney xenotransplantation: potential pathways behind proteinuria as well as factors related to growth discrepancies following pig-to-kidney xenotransplantation","author":"Shah","year":"2018","journal-title":"J Immunol Res"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1111\/tri.13273","article-title":"Upregulation of CD80 on glomerular podocytes plays an important role in development of proteinuria following pig-to-baboon xeno-renal transplantation \u2013 an experimental study","volume":"31","author":"Rivard","year":"2018","journal-title":"Transpl Int"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.33389\/fmed.2021.761600","article-title":"Molecular mechanisms of proteinuria in minimal change disease","volume":"8","author":"Purohit","year":"2021","journal-title":"Front Med December"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-014-2957-6","article-title":"Case series:CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis","volume":"30","author":"Garin","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-020-04541-3","article-title":"Glomerular endothelial cells and podocytes can express CD80 in patients with minimal change disease during relapse","volume":"35","author":"Cara-Fuentes","year":"2020","journal-title":"Pediatr Nephrol 20 June"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2022.09.014","article-title":"Circulating permeability factors in focal segmental glomerulosclerosis: in vitro detection","volume":"7","author":"Veissi","year":"2022","journal-title":"Kidney Int Rep"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2017.05.009","article-title":"Innate immune receptors as competitive determinants of cell fate","volume":"66","author":"Franz","year":"2017","journal-title":"Mol Cell"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2019.12.003","article-title":"Preventing CKD in developed countries","volume":"5","author":"Luyckx","year":"2020","journal-title":"Kidney Int Reports March"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.848389","article-title":"Novel therapies for alport syndrome","volume":"9","author":"Chavez","year":"2022","journal-title":"Front Med"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2022.04.011","article-title":"Putative role of STING-mitochondria associated membrane crosstalk in immunity","volume":"43","author":"Xue","year":"2022","journal-title":"Trends Immunol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001471","article-title":"Short-term pharmacological inhibition of MyD88 homodimerization by a novel inhibitor promotes robust allograft tolerance in mouse cardiac and skin transplantation","volume":"101","author":"Li","year":"2017","journal-title":"Transplantation"},{"key":"B89","doi-asserted-by":"publisher","first-page":"256ra136","DOI":"10.1126\/scitranslmed.3008538","article-title":"A circulating antibody panel for pre-transplant prediction of FSGS recurrence after kidney transplantation","volume":"6","author":"Delville","year":"2014","journal-title":"Sci Trans Med"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.023440","article-title":"TLR- mediated albuminuria needs TNF alpha-mediated cooperativity between TLRs present in hematopoietic tissues and CD80 present on non-hematopoietic tissues in mice","volume":"9","author":"Jain","year":"2016","journal-title":"Dis Models Mech"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1172\/JCI185939","article-title":"Local TNF causes NFATc1-dependent cholesterol-mediated podocyte injury","volume":"126","author":"Pedigo","year":"2016","journal-title":"J Clin Invest"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2021060794","article-title":"Discovery of autoantibodies targeting nephrin in minimal change disease supports a novel autoimmune etiology","volume":"33","author":"Watts","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-021-05196-4","article-title":"How immunosuppressive drugs may directly target podocytes in glomerular diseases","volume":"37","author":"Salvadori","year":"2022","journal-title":"Pediatr Nephrol July"},{"key":"B94","doi-asserted-by":"publisher","first-page":"13","DOI":"10.33594\/000000356","article-title":"Podocyte sphingolipid signaling in nephrotic syndrome","volume":"55","author":"Li","year":"2021","journal-title":"Cell Physiol Biochem"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe1312835","article-title":"A new era of podocyte-targeted therapy for proteinuric kidney disease","volume":"369","author":"Haraldsson","year":"2013","journal-title":"N Eng J Med"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.49","article-title":"The etiology of glomerulonephritis: roles of infection and autoimmunity","volume":"86","author":"Couser","year":"2014","journal-title":"Kidney Int"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN0000136312.46464.33","article-title":"Danger signaling by glomerular podocytes defines a novel function of inducible B7-1 in the pathogenesis of nephrotic syndrome","volume":"15","author":"Reiser","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1007\/s0047-022-05659-x","article-title":"Glomerular B7-1 staining: toward precision medicine for treatment of recurrent focal segmental glomerulosclerosis","volume":"38","author":"Wang","year":"2022","journal-title":"Pediatr Nephrol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1201619\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T07:13:05Z","timestamp":1690355585000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1201619\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,26]]},"references-count":98,"alternative-id":["10.3389\/fimmu.2023.1201619"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1201619","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,26]]},"article-number":"1201619"}}